A Study of CM310 in Patients With Moderate-to-Severe Atopic Dermatitis
Clinical trial NCT05265923 · COMPLETED
Trial details
- NCT number
- NCT05265923
- Sponsor
- Keymed Biosciences Co.Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-22
- Primary completion
- 2023-10-31
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.